Zymeworks (ZYME) Capital Expenditures (2021 - 2026)
Zymeworks recorded quarterly Capital Expenditures of $100000.0 in Q1 2026, up 110.64% quarter-over-quarter from -$940000.0 in Q4 2025, and up 525.0% year-over-year from $16000.0 in Q1 2025.
Zymeworks' Capital Expenditures history runs 6 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 525.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $84000.0 (up 425.0% YoY), while the FY2023 annual figure was $2.5 million, down 69.64% from the prior year.
- Capital Expenditures came in at $100000.0 for Q1 2026 at Zymeworks, up from -$940000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $6.7 million in Q4 2022 to a low of -$3.2 million in Q2 2022.
- A 5-year average of $670250.0 and a median of $419000.0 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures sank 571.07% in 2024 and surged 525.0% in 2026, its largest moves.
- Zymeworks' Capital Expenditures stood at $6.7 million in 2022, then sank by 94.7% to $356000.0 in 2023, then tumbled by 571.07% to -$1.7 million in 2024, then surged by 43.95% to -$940000.0 in 2025, then surged by 110.64% to $100000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $100000.0, -$940000.0, and $410000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | -940,000.00 |
| Dec 31, 2025 | -940,000.00 |
| Sep 30, 2025 | 410,000.00 |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Jun 30, 2025 | 514,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | -1.68 Mn |
| Dec 31, 2024 | -1.68 Mn |
| Sep 30, 2024 | 899,000.00 |
| Sep 30, 2024 | 899,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Dec 31, 2023 | 356,000.00 |
| Dec 31, 2023 | 356,000.00 |
| Sep 30, 2023 | 930,000.00 |
| Sep 30, 2023 | 930,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Jun 30, 2023 | 802,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Dec 31, 2022 | 6.72 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 428,000.00 |
| Sep 30, 2022 | 428,000.00 |
| Jun 30, 2022 | -3.16 Mn |
| Jun 30, 2022 | -3.16 Mn |
| Mar 31, 2022 | 4.16 Mn |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | 4.78 Mn |
| Dec 31, 2021 | 4.78 Mn |